Absolutely. I believe we have clearly demonstrated at BioCanRx what can be achieved when biomanufacturing is coordinated with the support required to submit clinical trial applications to Health Canada. We're seeing a huge increase in the number of clinical trials involving highly advanced therapies—new therapies that aren't yet available. This is new for Canada. First, our cancer patients need them. Second, they help drive investment in research in Canada. Third, they deserve it.
